Shi Y - Search Results

1

Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin's lymphoma.

Gui L, Han X, He X, Song Y, Yao J, Yang J, Liu P, Qin Y, Zhang S, Zhang W, Gai W, Xie L, Shi Y. Gui L, et al. Among authors: shi y. Chin J Cancer Res. 2016 Apr;28(2):197-208. doi: 10.21147/j.issn.1000-9604.2016.02.07. Chin J Cancer Res. 2016. PMID: 27199517 Free PMC article.

2

[Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].

Han X, Shi Y, Zhang W. Han X, et al. Among authors: shi y. Zhonghua Yi Xue Za Zhi. 2002 Feb 10;82(3):203-6. Zhonghua Yi Xue Za Zhi. 2002. PMID: 11953162 Chinese.

3

[Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor].

Shi Y, Han X, He X, Yang J, Liu P. Shi Y, et al. Zhonghua Yi Xue Za Zhi. 2002 Apr 10;82(7):462-6. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12133516 Clinical Trial. Chinese.

4

[Contamination with minimal residual disease in autologous peripheral stem cell collected from Non-Hodgkin's lymphoma patients treated with high-dose therapy].

Zhou A, Shi Y, Feng F, Lu S, He X, Han X. Zhou A, et al. Among authors: shi y. Zhonghua Zhong Liu Za Zhi. 2002 Sep;24(5):467-70. Zhonghua Zhong Liu Za Zhi. 2002. PMID: 12485501 Chinese.

5

Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.

Zhang B, Sun T, Xue L, Han X, Zhang B, Lu N, Shi Y, Tan W, Zhou Y, Zhao D, Zhang X, Guo Y, Lin D. Zhang B, et al. Among authors: shi y. Carcinogenesis. 2007 May;28(5):1067-73. doi: 10.1093/carcin/bgl250. Epub 2006 Dec 20. Carcinogenesis. 2007. PMID: 17183065

6

Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study.

Shi Y, He X, Yang S, Ai B, Zhang C, Huang D, Dong M, Liu P, Zhou S, Han X. Shi Y, et al. Chemotherapy. 2007;53(1):44-50. doi: 10.1159/000098418. Epub 2007 Jan 3. Chemotherapy. 2007. PMID: 17202811 Clinical Trial.

7

A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers.

Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, Guo Y, Yang M, Zhang X, Zhang Q, Zeng C, Lin D. Sun T, et al. Among authors: shi y. Nat Genet. 2007 May;39(5):605-13. doi: 10.1038/ng2030. Epub 2007 Apr 22. Nat Genet. 2007. PMID: 17450141

8

A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.

Wang M, Zhang L, Han X, Yang J, Qian J, Hong S, Lin P, Shi Y, Romaguera J, Kwak LW, Yi Q. Wang M, et al. Among authors: shi y. Clin Cancer Res. 2008 Apr 1;14(7):2154-60. doi: 10.1158/1078-0432.CCR-07-4409. Clin Cancer Res. 2008. PMID: 18381957 Free article.

9

Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines.

Huang D, Gao Q, Guo L, Zhang C, Jiang W, Li H, Wang J, Han X, Shi Y, Lu SH. Huang D, et al. Among authors: shi y. Stem Cells Dev. 2009 Apr;18(3):465-73. doi: 10.1089/scd.2008.0033. Stem Cells Dev. 2009. PMID: 18680391

10

Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer.

Sun T, Zhou Y, Yang M, Hu Z, Tan W, Han X, Shi Y, Yao J, Guo Y, Yu D, Tian T, Zhou X, Shen H, Lin D. Sun T, et al. Among authors: shi y. Cancer Res. 2008 Sep 1;68(17):7025-34. doi: 10.1158/0008-5472.CAN-08-0806. Cancer Res. 2008. PMID: 18757416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,590 results

Search Page

Filters